Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

InterStim Patients Must Keep Voiding Diary - CMS Coverage Decision

This article was originally published in The Gray Sheet

Executive Summary

Patients with urinary incontinence treated with sacral nerve stimulation (SNS) must keep a voiding diary to assess the therapy's effectiveness, according to a national Medicare coverage determination issued by CMS (formerly HCFA) on June 29.

You may also be interested in...



Medicare Reform Should Not Undercut Local Coverage Process – Medtronic

HHS should ensure that Medicare reform efforts to consolidate claims processing do not erode the autonomy of carrier medical directors to make local coverage decisions, Medtronic maintains in March 5 comments to the HHS Secretary's Advisory Committee on Regulatory Reform

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015117

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel